相似文献
1
Strategies to Optimize Treatment for Locally Advanced Rectal Cancer.
Cancers (Basel). 2022 Dec 29;15(1):219. doi: 10.3390/cancers15010219.
2
Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma.
BMC Cancer. 2020 Sep 1;20(1):831. doi: 10.1186/s12885-020-07333-y.
3
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
JAMA Oncol. 2018 Jun 14;4(6):e180071. doi: 10.1001/jamaoncol.2018.0071.
4
Current Practice Patterns in Locally Advanced Rectal Cancer at Academic Institutions: A National Survey Among Radiation Oncologists, Medical Oncologists, and Colorectal Surgeons.
Clin Colorectal Cancer. 2022 Dec;21(4):309-314. doi: 10.1016/j.clcc.2022.06.001. Epub 2022 Sep 16.
5
Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Eur J Surg Oncol. 2018 Jul;44(7):1013-1017. doi: 10.1016/j.ejso.2018.03.014. Epub 2018 Mar 23.
6
Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial.
BMJ Open. 2019 Mar 23;9(3):e025944. doi: 10.1136/bmjopen-2018-025944.
7
Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.
EClinicalMedicine. 2019 Oct 22;16:23-29. doi: 10.1016/j.eclinm.2019.09.009. eCollection 2019 Nov.
8
[Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Apr 25;22(4):349-356. doi: 10.3760/cma.j.issn.1671-0274.2019.04.007.
9
The effect of neoadjuvant short-course radiotherapy and delayed surgery versus chemoradiation on postoperative outcomes in locally advanced rectal cancer patients - A propensity score matched nationwide audit-based study.
Eur J Surg Oncol. 2020 Sep;46(9):1605-1612. doi: 10.1016/j.ejso.2020.03.002. Epub 2020 Mar 6.
10
Optimal Neoadjuvant Strategies for Locally Advanced Rectal Cancer by Risk Assessment and Tumor Location.
J Natl Compr Canc Netw. 2022 Oct;20(10):1177-1184. doi: 10.6004/jnccn.2022.7061.
引用本文的文献
1
Role of Senescence-Associated Biomarkers and Immune Dynamics in Predicting Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
Int J Gen Med. 2025 Apr 5;18:1957-1967. doi: 10.2147/IJGM.S508428. eCollection 2025.
2
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance.
J Exp Clin Cancer Res. 2024 May 30;43(1):151. doi: 10.1186/s13046-024-03078-9.
本文引用的文献
1
Changing patterns of neoadjuvant therapy for locally advanced rectal cancer: A narrative review.
Crit Rev Oncol Hematol. 2023 Jan;181:103885. doi: 10.1016/j.critrevonc.2022.103885. Epub 2022 Dec 2.
2
Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas.
N Engl J Med. 2022 Nov 3;387(18):1714-1716. doi: 10.1056/NEJMc2210175.
3
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2022 Oct;20(10):1139-1167. doi: 10.6004/jnccn.2022.0051.
4
MORPHEUS Phase II-III Study: A Pre-Planned Interim Safety Analysis and Preliminary Results.
Cancers (Basel). 2022 Jul 28;14(15):3665. doi: 10.3390/cancers14153665.
5
Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints Revisited.
Cancers (Basel). 2022 Jul 27;14(15):3658. doi: 10.3390/cancers14153658.
6
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.
N Engl J Med. 2022 Jun 23;386(25):2363-2376. doi: 10.1056/NEJMoa2201445. Epub 2022 Jun 5.
7
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.
J Clin Oncol. 2022 Aug 10;40(23):2546-2556. doi: 10.1200/JCO.22.00032. Epub 2022 Apr 28.
8
Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR).
J Clin Oncol. 2022 May 20;40(15):1681-1692. doi: 10.1200/JCO.21.01667. Epub 2022 Mar 9.
9
Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-Analysis.
Cancers (Basel). 2021 Nov 30;13(23):6035. doi: 10.3390/cancers13236035.
10
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial.
JAMA Oncol. 2022 Jan 1;8(1):e215445. doi: 10.1001/jamaoncol.2021.5445. Epub 2022 Jan 20.
Zotero 插件